blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3969608

EP3969608 - NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.07.2024
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  18.02.2022
FormerThe international publication has been made
Status updated on  20.11.2020
Most recent event   Tooltip19.07.2024Application deemed to be withdrawnpublished on 21.08.2024  [2024/34]
Applicant(s)For all designated states
Veracyte SD, Inc.
6925 Lusk Blvd
Suite 200
San Diego, CA 92121 / US
For all designated states
Erasmus University Medical Center Rotterdam
Dr. Molewaterplein 40
3015 GD Rotterdam / NL
[2023/48]
Former [2022/12]For all designated states
Decipher Biosciences, Inc.
10355 Science Center Drive, Suite 240
San Diego, CA 92121 / US
For all designated states
Erasmus University Medical Center Rotterdam
Dr. Molewaterplein 40
3015 GD Rotterdam / NL
Inventor(s)01 / DE JONG, Joep Jacobus
c/o Erasmus University Medical Center
Dr. Molewaterplein 40
3015 GD Rotterdam / NL
02 / LIU, Yang
c/o Decipher Biosciences, Inc.
10355 Science Center Drive, Suite 240
San Diego, California 92121 / US
03 / GIBB, Ewan A.
c/o Decipher Biosciences, Inc.
10355 Science Center Drive, Suite 240
San Diego, California 92121 / US
04 / DAVICIONI, Elai
c/o Decipher Biosciences, Inc.
10355 Science Center Drive, Suite 240
San Diego, California 92121 / US
 [2022/12]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[N/P]
Former [2022/12]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
Application number, filing date20805861.012.05.2020
[2022/12]
WO2020US32484
Priority number, dateUS201962848799P16.05.2019         Original published format: US 201962848799 P
[2022/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020231997
Date:19.11.2020
Language:EN
[2020/47]
Type: A1 Application with search report 
No.:EP3969608
Date:23.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 19.11.2020 takes the place of the publication of the European patent application.
[2022/12]
Search report(s)International search report - published on:RU19.11.2020
(Supplementary) European search report - dispatched on:EP25.08.2023
ClassificationIPC:C12Q1/68, C12Q1/6806, C12Q1/686, C12Q1/6869, C12Q1/6876, C12Q1/6883, C12Q1/6886, G01N33/574
[2022/12]
CPC:
G01N33/57407 (EP); C12Q1/6886 (EP,US); C12Q2600/106 (EP,US);
C12Q2600/112 (EP,US); C12Q2600/118 (EP,US); C12Q2600/158 (EP,US);
C12Q2600/178 (EP,US); G01N2800/52 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/12]
TitleGerman:NICHTCODIERENDE RNA ZUR SUBTYPISIERUNG VON BLASENKREBS[2022/12]
English:NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER[2022/12]
French:ARN NON CODANT POUR LE TRAITEMENT DU CANCER DE LA VESSIE[2022/12]
Entry into regional phase16.12.2021National basic fee paid 
16.12.2021Search fee paid 
16.12.2021Designation fee(s) paid 
16.12.2021Examination fee paid 
Examination procedure16.12.2021Examination requested  [2022/12]
01.08.2022Amendment by applicant (claims and/or description)
23.03.2024Application deemed to be withdrawn, date of legal effect  [2024/34]
16.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2024/34]
Fees paidRenewal fee
01.02.2022Renewal fee patent year 03
20.03.2023Renewal fee patent year 04
06.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2015073949  (UNIV NORTH CAROLINA [US]) [A] 1-15 * the whole document *;
 [I]  - ROBERTSON A GORDON ET AL, "Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer", CELL, (20171019), vol. 171, no. 3, doi:10.1016/J.CELL.2017.09.007, ISSN 0092-8674, page 540, XP085233873 [I] 4-11 * figures 2, 4, 7 *

DOI:   http://dx.doi.org/10.1016/j.cell.2017.09.007
 [A]  - SEILER ROLAND ET AL, "Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy", EUROPEAN UROLOGY, ELSEVIER, AMSTERDAM, NL, (20170405), vol. 72, no. 4, doi:10.1016/J.EURURO.2017.03.030, ISSN 0302-2838, pages 544 - 554, XP085198426 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.eururo.2017.03.030
 [X]  - AFFYMETRIX, "GeneChip exon array system for human, mouse, and rat", INTERNET CITATION, (20060101), URL: http://www.affymetrix.com/products/arrays/exon_application.affx, XP002480421 [X] 12-15 * the whole document *
International search[X]US2010137164  (RUBIN MARK A [US], et al) [X] 32, 34-36 * , claims, paragraph [0060] *;
 [XY]WO2018132916  (GENOMEDX BIOSCIENCES INC [CA]) [X] 33 * , claims, paragraphs [0011]-[0019], [0023], [0025]-[0029], [00127], [00135], [00152], [00159] * [Y] 1-3, 5, 6, 21-25, 30, 31, 37-39;
 [Y]  - INAMURA KENTARO, "Bladder Cancer: New Insights into Its Molecular Pathology", Cancers (Basel, (20180000), vol. 10, no. 4, doi:10.3390/cancersl0040100, pages 100; 1 - 14, XP055639543 [Y] 1-3, 5, 6, 21-25, 30, 31, 37-39 * , chapters 2.1, 2.3, 3, 4, 4.2, p. 8-9 *

DOI:   http://dx.doi.org/10.3390/cancers10040100
 [A]  - WARRICK JOSHUA I. et al., "FOXA1, GATA3 and PPARy Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines", Scientific Reports, (20160000), vol. 6, no. 38531, doi:10.1038/srep38531, pages 1 - 15, XP055639530 [A] 1-3, 5, 6, 21-25, 30-39

DOI:   http://dx.doi.org/10.1038/srep38531
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.